ADMIRE Trademark

Trademark Overview

On Friday, June 30, 2023, a trademark application was filed for ADMIRE with the United States Patent and Trademark Office. The USPTO has given the ADMIRE trademark a serial number of 98066290. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Thursday, September 19, 2024. This trademark is owned by Abbvie Inc.. The ADMIRE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

providing information about medical clinical trials, namely, information in the field of improving diversity and inclusion in clinical research studies and clinical trials.
admire

General Information

Serial Number98066290
Word MarkADMIRE
Filing DateFriday, June 30, 2023
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 14, 2023

Trademark Statements

Description of MarkThe mark consists of The word "admire" with stylized parenthesis on both sides that appear as half circle shapes.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesproviding information about medical clinical trials, namely, information in the field of improving diversity and inclusion in clinical research studies and clinical trials.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 1, 2023
Primary Code042
First Use Anywhere DateTuesday, January 31, 2023
First Use In Commerce DateTuesday, January 31, 2023

Trademark Owner History

Party NameAbbvie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbvie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Tuesday, July 4, 2023NEW APPLICATION ENTERED
Tuesday, August 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 2, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 5, 2023ASSIGNED TO EXAMINER
Monday, October 9, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, October 9, 2023EXAMINERS AMENDMENT E-MAILED
Monday, October 9, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 9, 2023EXAMINER'S AMENDMENT ENTERED
Monday, October 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, July 14, 2024SOU EXTENSION 1 FILED
Sunday, July 14, 2024USE AMENDMENT FILED
Sunday, July 14, 2024PETITION TO REVIVE-GRANTED
Sunday, July 14, 2024NOTICE OF REVIVAL - E-MAILED
Sunday, July 14, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, September 16, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, September 16, 2024SOU EXTENSION 1 GRANTED
Monday, September 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 19, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, September 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 19, 2024NON-FINAL ACTION E-MAILED
Sunday, July 14, 2024TEAS STATEMENT OF USE RECEIVED
Sunday, July 14, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION

Related Keywords

admire clinical trials information diversity inclusion research studies improving namely about